The association of erectile dysfunction with productivity and absenteeism in eight countries globally.
Identifieur interne : 000402 ( Main/Exploration ); précédent : 000401; suivant : 000403The association of erectile dysfunction with productivity and absenteeism in eight countries globally.
Auteurs : Irwin Goldstein [États-Unis] ; Amir Goren [États-Unis] ; Vicky W. Li [États-Unis] ; Martine C. Maculaitis [États-Unis] ; Wing Yu Tang [États-Unis] ; Tarek A. Hassan [États-Unis]Source :
- International journal of clinical practice [ 1742-1241 ] ; 2019.
Descripteurs français
- KwdFr :
- Absentéisme (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Allemagne (épidémiologie), Autorapport (MeSH), Brésil (épidémiologie), Chine (épidémiologie), Dysfonctionnement érectile (épidémiologie), Enquêtes de santé (MeSH), Espagne (épidémiologie), Femelle (MeSH), France (épidémiologie), Humains (MeSH), Italie (épidémiologie), Mâle (MeSH), Présentéisme (MeSH), Qualité de vie (psychologie), Sujet âgé (MeSH), Études transversales (MeSH).
- MESH :
- psychologie : Qualité de vie.
- épidémiologie : Allemagne, Brésil, Chine, Dysfonctionnement érectile, Espagne, France, Italie.
- Absentéisme, Adulte, Adulte d'âge moyen, Autorapport, Enquêtes de santé, Femelle, Humains, Mâle, Présentéisme, Sujet âgé, Études transversales.
- Wicri :
English descriptors
- KwdEn :
- Absenteeism (MeSH), Adult (MeSH), Aged (MeSH), Brazil (epidemiology), China (epidemiology), Cross-Sectional Studies (MeSH), Erectile Dysfunction (epidemiology), Female (MeSH), France (epidemiology), Germany (epidemiology), Health Surveys (MeSH), Humans (MeSH), Italy (epidemiology), Male (MeSH), Middle Aged (MeSH), Presenteeism (MeSH), Quality of Life (psychology), Self Report (MeSH), Spain (epidemiology).
- MESH :
- geographic , epidemiology : Brazil, China, France, Germany, Italy, Spain.
- epidemiology : Erectile Dysfunction.
- psychology : Quality of Life.
- Absenteeism, Adult, Aged, Cross-Sectional Studies, Female, Health Surveys, Humans, Male, Middle Aged, Presenteeism, Self Report.
Abstract
AIM
To evaluate the association of erectile dysfunction (ED) with work productivity loss, activity impairment and health-related quality of life (HRQoL) across Brazil, China, France, Germany, Italy, Spain, the UK and the US.
METHODS
This cross-sectional observational study used data from adult men (40-70 years old; N = 52 697) from the 2015 and 2016 National Health and Wellness Surveys. ED assessment was based on self-reported difficulty in achieving or maintaining an erection in the past 6 months. Impairment to work and non-work activities and HRQoL were assessed for each country and compared against the US. Multivariable models tested interactions between ED status and country for each outcome.
RESULTS
Overall ED prevalence was reported as 49.7%, with Italy reporting the highest rate (54.7%). Men with ED reported significantly higher absenteeism (7.1% vs 3.2%), presenteeism (22.5% vs 10.1%), overall work productivity impairment (24.8% vs 11.2%), activity impairment (28.6% vs 14.5%) and significantly lower Mental Component Summary scores (MCS; 46.7 vs 51.2), Physical Component Summary scores (PCS; 48.3 vs 53.0), and health state utilities (SF-6D: 0.693 vs 0.778; all, P < 0.001) than men with no ED. After adjusting for covariates, compared with the US, the association of ED status with overall work productivity impairment was greatest in the UK (26% higher; P < 0.05), and with MCS, PCS and SF-6D scores was greatest in China (-2.67, -1.58, and -0.043 points, respectively; all, P < 0.001). Greater ED severity was significantly associated with higher impairment to work and non-work activities and lower HRQoL, with China reporting the highest burden, compared with the US (most P < 0.05).
CONCLUSION
ED poses a significant burden with respect to work productivity and HRQoL, with greater severity associated with worse outcomes. Better management and earlier detection may help reduce this burden, especially in countries reporting a strong association between ED and poor economic and health outcomes.
DOI: 10.1111/ijcp.13384
PubMed: 31389146
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The association of erectile dysfunction with productivity and absenteeism in eight countries globally.</title><author><name sortKey="Goldstein, Irwin" sort="Goldstein, Irwin" uniqKey="Goldstein I" first="Irwin" last="Goldstein">Irwin Goldstein</name><affiliation wicri:level="2"><nlm:affiliation>Director of Sexual Medicine, Alvarado Hospital, San Diego, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Director of Sexual Medicine, Alvarado Hospital, San Diego</wicri:cityArea></affiliation></author><author><name sortKey="Goren, Amir" sort="Goren, Amir" uniqKey="Goren A" first="Amir" last="Goren">Amir Goren</name><affiliation wicri:level="2"><nlm:affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Health Outcomes Practice, Kantar Health, New York</wicri:cityArea></affiliation></author><author><name sortKey="Li, Vicky W" sort="Li, Vicky W" uniqKey="Li V" first="Vicky W" last="Li">Vicky W. Li</name><affiliation wicri:level="2"><nlm:affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Health Outcomes Practice, Kantar Health, New York</wicri:cityArea></affiliation></author><author><name sortKey="Maculaitis, Martine C" sort="Maculaitis, Martine C" uniqKey="Maculaitis M" first="Martine C" last="Maculaitis">Martine C. Maculaitis</name><affiliation wicri:level="2"><nlm:affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Health Outcomes Practice, Kantar Health, New York</wicri:cityArea></affiliation></author><author><name sortKey="Tang, Wing Yu" sort="Tang, Wing Yu" uniqKey="Tang W" first="Wing Yu" last="Tang">Wing Yu Tang</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Inc, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Pfizer Inc, New York</wicri:cityArea></affiliation></author><author><name sortKey="Hassan, Tarek A" sort="Hassan, Tarek A" uniqKey="Hassan T" first="Tarek A" last="Hassan">Tarek A. Hassan</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Inc, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Pfizer Inc, New York</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31389146</idno><idno type="pmid">31389146</idno><idno type="doi">10.1111/ijcp.13384</idno><idno type="wicri:Area/Main/Corpus">000393</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000393</idno><idno type="wicri:Area/Main/Curation">000393</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000393</idno><idno type="wicri:Area/Main/Exploration">000393</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The association of erectile dysfunction with productivity and absenteeism in eight countries globally.</title><author><name sortKey="Goldstein, Irwin" sort="Goldstein, Irwin" uniqKey="Goldstein I" first="Irwin" last="Goldstein">Irwin Goldstein</name><affiliation wicri:level="2"><nlm:affiliation>Director of Sexual Medicine, Alvarado Hospital, San Diego, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Director of Sexual Medicine, Alvarado Hospital, San Diego</wicri:cityArea></affiliation></author><author><name sortKey="Goren, Amir" sort="Goren, Amir" uniqKey="Goren A" first="Amir" last="Goren">Amir Goren</name><affiliation wicri:level="2"><nlm:affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Health Outcomes Practice, Kantar Health, New York</wicri:cityArea></affiliation></author><author><name sortKey="Li, Vicky W" sort="Li, Vicky W" uniqKey="Li V" first="Vicky W" last="Li">Vicky W. Li</name><affiliation wicri:level="2"><nlm:affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Health Outcomes Practice, Kantar Health, New York</wicri:cityArea></affiliation></author><author><name sortKey="Maculaitis, Martine C" sort="Maculaitis, Martine C" uniqKey="Maculaitis M" first="Martine C" last="Maculaitis">Martine C. Maculaitis</name><affiliation wicri:level="2"><nlm:affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Health Outcomes Practice, Kantar Health, New York</wicri:cityArea></affiliation></author><author><name sortKey="Tang, Wing Yu" sort="Tang, Wing Yu" uniqKey="Tang W" first="Wing Yu" last="Tang">Wing Yu Tang</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Inc, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Pfizer Inc, New York</wicri:cityArea></affiliation></author><author><name sortKey="Hassan, Tarek A" sort="Hassan, Tarek A" uniqKey="Hassan T" first="Tarek A" last="Hassan">Tarek A. Hassan</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Inc, New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Pfizer Inc, New York</wicri:cityArea></affiliation></author></analytic><series><title level="j">International journal of clinical practice</title><idno type="eISSN">1742-1241</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Absenteeism (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Brazil (epidemiology)</term><term>China (epidemiology)</term><term>Cross-Sectional Studies (MeSH)</term><term>Erectile Dysfunction (epidemiology)</term><term>Female (MeSH)</term><term>France (epidemiology)</term><term>Germany (epidemiology)</term><term>Health Surveys (MeSH)</term><term>Humans (MeSH)</term><term>Italy (epidemiology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Presenteeism (MeSH)</term><term>Quality of Life (psychology)</term><term>Self Report (MeSH)</term><term>Spain (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Absentéisme (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Allemagne (épidémiologie)</term><term>Autorapport (MeSH)</term><term>Brésil (épidémiologie)</term><term>Chine (épidémiologie)</term><term>Dysfonctionnement érectile (épidémiologie)</term><term>Enquêtes de santé (MeSH)</term><term>Espagne (épidémiologie)</term><term>Femelle (MeSH)</term><term>France (épidémiologie)</term><term>Humains (MeSH)</term><term>Italie (épidémiologie)</term><term>Mâle (MeSH)</term><term>Présentéisme (MeSH)</term><term>Qualité de vie (psychologie)</term><term>Sujet âgé (MeSH)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Brazil</term><term>China</term><term>France</term><term>Germany</term><term>Italy</term><term>Spain</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Erectile Dysfunction</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Qualité de vie</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Quality of Life</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Brésil</term><term>Chine</term><term>Dysfonctionnement érectile</term><term>Espagne</term><term>France</term><term>Italie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Absenteeism</term><term>Adult</term><term>Aged</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Surveys</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Presenteeism</term><term>Self Report</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Absentéisme</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Autorapport</term><term>Enquêtes de santé</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Présentéisme</term><term>Sujet âgé</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Brésil</term><term>République populaire de Chine</term><term>France</term><term>Allemagne</term><term>Italie</term><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>AIM</b></p><p>To evaluate the association of erectile dysfunction (ED) with work productivity loss, activity impairment and health-related quality of life (HRQoL) across Brazil, China, France, Germany, Italy, Spain, the UK and the US.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>This cross-sectional observational study used data from adult men (40-70 years old; N = 52 697) from the 2015 and 2016 National Health and Wellness Surveys. ED assessment was based on self-reported difficulty in achieving or maintaining an erection in the past 6 months. Impairment to work and non-work activities and HRQoL were assessed for each country and compared against the US. Multivariable models tested interactions between ED status and country for each outcome.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Overall ED prevalence was reported as 49.7%, with Italy reporting the highest rate (54.7%). Men with ED reported significantly higher absenteeism (7.1% vs 3.2%), presenteeism (22.5% vs 10.1%), overall work productivity impairment (24.8% vs 11.2%), activity impairment (28.6% vs 14.5%) and significantly lower Mental Component Summary scores (MCS; 46.7 vs 51.2), Physical Component Summary scores (PCS; 48.3 vs 53.0), and health state utilities (SF-6D: 0.693 vs 0.778; all, P < 0.001) than men with no ED. After adjusting for covariates, compared with the US, the association of ED status with overall work productivity impairment was greatest in the UK (26% higher; P < 0.05), and with MCS, PCS and SF-6D scores was greatest in China (-2.67, -1.58, and -0.043 points, respectively; all, P < 0.001). Greater ED severity was significantly associated with higher impairment to work and non-work activities and lower HRQoL, with China reporting the highest burden, compared with the US (most P < 0.05).</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>ED poses a significant burden with respect to work productivity and HRQoL, with greater severity associated with worse outcomes. Better management and earlier detection may help reduce this burden, especially in countries reporting a strong association between ED and poor economic and health outcomes.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31389146</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1742-1241</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>International journal of clinical practice</Title><ISOAbbreviation>Int J Clin Pract</ISOAbbreviation></Journal><ArticleTitle>The association of erectile dysfunction with productivity and absenteeism in eight countries globally.</ArticleTitle><Pagination><MedlinePgn>e13384</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.13384</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the association of erectile dysfunction (ED) with work productivity loss, activity impairment and health-related quality of life (HRQoL) across Brazil, China, France, Germany, Italy, Spain, the UK and the US.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This cross-sectional observational study used data from adult men (40-70 years old; N = 52 697) from the 2015 and 2016 National Health and Wellness Surveys. ED assessment was based on self-reported difficulty in achieving or maintaining an erection in the past 6 months. Impairment to work and non-work activities and HRQoL were assessed for each country and compared against the US. Multivariable models tested interactions between ED status and country for each outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall ED prevalence was reported as 49.7%, with Italy reporting the highest rate (54.7%). Men with ED reported significantly higher absenteeism (7.1% vs 3.2%), presenteeism (22.5% vs 10.1%), overall work productivity impairment (24.8% vs 11.2%), activity impairment (28.6% vs 14.5%) and significantly lower Mental Component Summary scores (MCS; 46.7 vs 51.2), Physical Component Summary scores (PCS; 48.3 vs 53.0), and health state utilities (SF-6D: 0.693 vs 0.778; all, P < 0.001) than men with no ED. After adjusting for covariates, compared with the US, the association of ED status with overall work productivity impairment was greatest in the UK (26% higher; P < 0.05), and with MCS, PCS and SF-6D scores was greatest in China (-2.67, -1.58, and -0.043 points, respectively; all, P < 0.001). Greater ED severity was significantly associated with higher impairment to work and non-work activities and lower HRQoL, with China reporting the highest burden, compared with the US (most P < 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ED poses a significant burden with respect to work productivity and HRQoL, with greater severity associated with worse outcomes. Better management and earlier detection may help reduce this burden, especially in countries reporting a strong association between ED and poor economic and health outcomes.</AbstractText><CopyrightInformation>© 2019 John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Irwin</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Director of Sexual Medicine, Alvarado Hospital, San Diego, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goren</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Vicky W</ForeName><Initials>VW</Initials><AffiliationInfo><Affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maculaitis</LastName><ForeName>Martine C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Health Outcomes Practice, Kantar Health, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Wing Yu</ForeName><Initials>WY</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-2951-151X</Identifier><AffiliationInfo><Affiliation>Pfizer Inc, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Tarek A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Pfizer Inc, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Pfizer</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Clin Pract</MedlineTA><NlmUniqueID>9712381</NlmUniqueID><ISSNLinking>1368-5031</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000041" MajorTopicYN="Y">Absenteeism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007172" MajorTopicYN="N">Erectile Dysfunction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069597" MajorTopicYN="N">Presenteeism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brazil</Keyword><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">European Union</Keyword><Keyword MajorTopicYN="N">United States</Keyword><Keyword MajorTopicYN="N">absenteeism</Keyword><Keyword MajorTopicYN="N">health-related quality of life</Keyword><Keyword MajorTopicYN="N">presenteeism</Keyword><Keyword MajorTopicYN="N">work productivity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31389146</ArticleId><ArticleId IdType="doi">10.1111/ijcp.13384</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>McCabe MP, Sharlip ID, Atalla E, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:135-143. https://doi.org/10.1016/j.jsxm.2015.12.019</Citation></Reference><Reference><Citation>Yafi FA, Jenkins L, Albersen M, et al. Erectile dysfunction. Nat Rev Dis Prim. 2016;2:16003. https://doi.org/10.1038/nrdp.2016.3</Citation></Reference><Reference><Citation>Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 1994;151:54-61.</Citation></Reference><Reference><Citation>Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50-56.</Citation></Reference><Reference><Citation>Nicolosi A, Laumann EO, Glasser DB, Moreira ED, Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology. 2004;64:991-997. https://doi.org/10.1016/j.urology.2004.06.055</Citation></Reference><Reference><Citation>Mulhall J, King R, Glina S, Hvidsten K. Importance of and satisfaction with sex among men and women worldwide: results of the global better sex survey. J Sex Med. 2008;5:788-795. https://doi.org/10.1111/j.1743-6109.2007.00765.x</Citation></Reference><Reference><Citation>Goldstein I, Goren A, Li VW, Tang WY, Hassan TA. Global prevalence, patient profiles, and health outcomes of Erectile Dysfunction (ED) among 40-70 Year-old Men. J Sex Med. 2018;15:S29-S30. https://doi.org/10.1016/j.jsxm.2017.11.082</Citation></Reference><Reference><Citation>Dean J. Characterisation, prevalence, and consultation rates of erectile dysfunction. Clin Cornerstone. 2005;7:5-11.</Citation></Reference><Reference><Citation>Guest JF, Das GR. Health-related quality of life in a UK-based population of men with erectile dysfunction. Pharmacoeconomics. 2002;20:109-117.</Citation></Reference><Reference><Citation>Agaba PA, Ocheke AN, Akanbi MO, et al. Sexual functioning and health-related quality of life in men. Niger Med J. 2017;58:96-100. https://doi.org/10.4103/nmj.NMJ_225_16</Citation></Reference><Reference><Citation>Jannini EA, Sternbach N, Limoncin E, et al. Health-related characteristics and unmet needs of men with erectile dysfunction: a survey in five European Countries. J Sex Med. 2014;11:40-50. https://doi.org/10.1111/jsm.12344</Citation></Reference><Reference><Citation>Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med. 1998;13:159-166. https://doi.org/10.1046/j.1525-1497.1998.00050.x</Citation></Reference><Reference><Citation>Lau J, Kim JH, Tsui H-Y. Prevalence of male and female sexual problems, perceptions related to sex and association with quality of life in a Chinese population: a population-based study. Int J Impot Res. 2005;17:494-505. https://doi.org/10.1038/sj.ijir.3901342</Citation></Reference><Reference><Citation>Hoffman BM, Sherwood A, Smith PJ, et al. Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men. Int J Impot Res. 2010;22:30-35. https://doi.org/10.1038/ijir.2009.43</Citation></Reference><Reference><Citation>Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. https://doi.org/10.1136/bmj.j2099.</Citation></Reference><Reference><Citation>Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200:423-432. https://doi.org/10.1016/j.juro.2018.03.115</Citation></Reference><Reference><Citation>Chapnick J, Gross HJ, Pomerantz D, Mould J. Understanding differences among erectile dysfunction patients globally. Value Heal. 2013;16:A77. https://doi.org/10.1016/j.jval.2013.03.349</Citation></Reference><Reference><Citation>Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/Epidemiology/Risk factors for sexual dysfunction. J Sex Med. 2010;7:1598-1607. https://doi.org/10.1111/j.1743-6109.2010.01778.x</Citation></Reference><Reference><Citation>Wang W, Fan J, Huang G, et al. Meta-analysis of prevalence of erectile dysfunction in mainland China: evidence based on epidemiological surveys. Sex Med. 2017;5:e19-e30. https://doi.org/10.1016/j.esxm.2016.10.001</Citation></Reference><Reference><Citation>Kantar Health. National Health and Wellness Survey. Patient-Reported Healthcare Insights. New York; 2016. http://www.kantarhealth.com/docs/datasheets/kh-national-health-and-wellness-survey.pdf. Accessed December 6, 2018.</Citation></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.</Citation></Reference><Reference><Citation>Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353-365.</Citation></Reference><Reference><Citation>Maruish M, ed. User’s Manual for the SF-36v2 Health Survey, 3rd edn. Quality Metric Incorporated: Lincoln; 2011.</Citation></Reference><Reference><Citation>Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271-292.</Citation></Reference><Reference><Citation>Corona G, Lee DM, Forti G, et al. Age-related changes in general and sexual health in middle-aged and older men: Results from the European male ageing study (EMAS). J Sex Med. 2010;7:1362-1380. https://doi.org/10.1111/j.1743-6109.2009.01601.x</Citation></Reference><Reference><Citation>Sánchez-Cruz JJ, Cabrera-León A, Martín-Morales A, Fernández A, Burgos R, Rejas J. Male erectile dysfunction and health-related quality of life. Eur Urol. 2003;44:245-253.</Citation></Reference><Reference><Citation>Goldstein I, Goren A, Li V, Tang WY, Hassan TA. Erectile dysfunction prevalence, patient characteristics, and health outcomes globally. J Sex Med. 2017;14:e298. https://doi.org/10.1016/j.jsxm.2017.04.433</Citation></Reference><Reference><Citation>Jannini EA, Nappi RE. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause. Sex Med Rev. 2018;6:384-395. https://doi.org/10.1016/j.sxmr.2017.11.002</Citation></Reference><Reference><Citation>Brooke JC, Walter DJ, Kapoor D, Marsh H, Muraleedharan V, Jones TH. Testosterone deficiency and severity of erectile dysfunction are independently associated with reduced quality of life in men with type 2 diabetes. Andrology. 2014;2:205-211. https://doi.org/10.1111/j.2047-2927.2013.00177.x</Citation></Reference><Reference><Citation>Swigris JJ, Brown KK, Behr J, et al. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med. 2010;104:296-304. https://doi.org/10.1016/J.RMED.2009.09.006</Citation></Reference><Reference><Citation>Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523-1532.</Citation></Reference><Reference><Citation>Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151-157. https://doi.org/10.1016/j.amjmed.2006.06.010</Citation></Reference><Reference><Citation>Goldstein I, Goren A, Liebert R, Tang WY, Hassan TA. 145 Exploratory cluster analysis of US males 40-70 years old focused on erectile dysfunction and associated risk factors, using National Health and Wellness Survey data. J Sex Med. 2018;15:S190-S191. https://doi.org/10.1016/j.jsxm.2018.04.147</Citation></Reference><Reference><Citation>Salonia A, Capogrosso P, Clementi MC, Castagna G, Damiano R, Montorsi F. Is erectile dysfunction a reliable indicator of general health status in men? Arab J Urol. 2013;11:203-211. https://doi.org/10.1016/j.aju.2013.07.008</Citation></Reference><Reference><Citation>DiBernardo A, Lin X, Zhang Q, et al. Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study. BMC Psychiatry. 2018;18:352. https://doi.org/10.1186/s12888-018-1920-7</Citation></Reference><Reference><Citation>Gupta S, Richard L, Forsythe A. The humanistic and economic burden associated with increasing body mass index in the EU5. Diabetes, Metab Syndr Obes Targets Ther. 2015;8:327. https://doi.org/10.2147/DMSO.S83696</Citation></Reference><Reference><Citation>Bolge SC, Flores NM, Phan JH. The burden of poor mental well-being among patients with type 2 diabetes mellitus. J Occup Environ Med. 2016;58:1121-1126. https://doi.org/10.1097/JOM.0000000000000874</Citation></Reference><Reference><Citation>Jannini EA. SM = SM: the interface of systems medicine and sexual medicine for facing non-communicable diseases in a gender-dependent manner. Sex Med Rev. 2017;5:349-364. https://doi.org/10.1016/j.sxmr.2017.04.002</Citation></Reference><Reference><Citation>Rosen R, Riley A, Wagner G, Osterloh I, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822-830.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Goldstein, Irwin" sort="Goldstein, Irwin" uniqKey="Goldstein I" first="Irwin" last="Goldstein">Irwin Goldstein</name></region><name sortKey="Goren, Amir" sort="Goren, Amir" uniqKey="Goren A" first="Amir" last="Goren">Amir Goren</name><name sortKey="Hassan, Tarek A" sort="Hassan, Tarek A" uniqKey="Hassan T" first="Tarek A" last="Hassan">Tarek A. Hassan</name><name sortKey="Li, Vicky W" sort="Li, Vicky W" uniqKey="Li V" first="Vicky W" last="Li">Vicky W. Li</name><name sortKey="Maculaitis, Martine C" sort="Maculaitis, Martine C" uniqKey="Maculaitis M" first="Martine C" last="Maculaitis">Martine C. Maculaitis</name><name sortKey="Tang, Wing Yu" sort="Tang, Wing Yu" uniqKey="Tang W" first="Wing Yu" last="Tang">Wing Yu Tang</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000402 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000402 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:31389146
|texte= The association of erectile dysfunction with productivity and absenteeism in eight countries globally.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:31389146" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |